BIOXYTRAN’s Universal Oxygen Carrier Vs. Blood Substitutes: A Contemporary Evidence‑Based Review
March 24, 2026 David Platt, PhD Bioxytran, Inc. Scope and purpose This review summarizes scientific principles, major classes, clinical development history, safety challenges, manufacturing and regulatory considerations, ethical/logistical/economic issues, and realistic future directions for blood substitutes and oxygen therapeutics. Numbered intext citations refer to peer‑reviewed studies, regulatory documents, and authoritative reviews listed in the […]










